Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety - Top-Institutions - MDSpire

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety

  • By

  • Yaping Quan

  • Zhengjie Liang

  • Yunhao Wei

  • Hao Li

  • Yan Zeng

  • Jie Shen

  • Shengfa Su

  • Xian Liu

  • Zhongjun Huang

  • Minfang Wang

  • Hongyan Luo

  • Yong Hu

  • Jie Peng

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Guiyang Public Health Clinical Center
    Guiyang Public Health Clinical Center

    Guiyang, Guizhou

    Key Differentiators

    • Oncology

  • #2

    Shanghai Chest Hospital
    Shanghai Chest Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Oncology

  • #3

    School of Medicine, Shanghai Jiao Tong University
    School of Medicine, Shanghai Jiao Tong University

    Shanghai, Shanghai

    Key Differentiators

    • Oncology

  • #4

    Levine Cancer Institute, Atrium Health
    Levine Cancer Institute, Atrium Health

    Charlotte, North Carolina

    Key Differentiators

    • Oncology

  • #5

    Trinity St. James’s Cancer Institute
    Trinity St. James’s Cancer Institute

    Dublin, Ireland

    Key Differentiators

    • Oncology

Original Source(s)

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety

  • by Yaping Quan, Zhengjie Liang, Yunhao Wei, Hao Li, Yan Zeng, Jie Shen, Shengfa Su, Xian Liu, Zhongjun Huang, Minfang Wang, Hongyan Luo, Yong Hu, Jie Peng

  • July 15, 2026

Related Content

Galectins at the crossroads of tumor immunity, metabolism, and metastasis: mechanisms, therapeutic resistance, and translational opportunities

A hybrid ViT-L/32–MaxViT-L architecture with adaptive gated fusion for multiclass gastrointestinal disease detection and multi-method post-hoc explainability

Editorial: The multifaceted role of cholangiocytes in neoplastic and non-neoplastic cholangiopathies: from bench to bedside